1. Home
  2. VERU vs KBSX Comparison

VERU vs KBSX Comparison

Compare VERU & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.54

Market Cap

44.0M

Sector

Health Care

ML Signal

HOLD

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

HOLD

Current Price

$1.68

Market Cap

50.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
KBSX
Founded
1971
1976
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.0M
50.6M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
VERU
KBSX
Price
$2.54
$1.68
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $22.50
N/A
AVG Volume (30 Days)
★ 187.4K
16.6K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $16,296,958.00
N/A
Revenue This Year
N/A
$18.65
Revenue Next Year
N/A
$16.31
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.05
$0.81
52 Week High
$7.33
$1.77

Technical Indicators

Market Signals
Indicator
VERU
KBSX
Relative Strength Index (RSI) 51.59 79.16
Support Level $2.50 $1.11
Resistance Level $2.60 N/A
Average True Range (ATR) 0.10 0.13
MACD 0.01 0.06
Stochastic Oscillator 44.69 100.00

Price Performance

Historical Comparison
VERU
KBSX

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: